Symptomer fra lungerne såsom hoste og dyspnø, kan være grund til at stoppe behandlingen og til at foretage yderligere passende undersøgelser.
Pulmonary symptoms, such as cough and dyspnoea, may be a reason for discontinuation of the therapy and for further investigation, as appropriate.